Quanterix (QTRX) Net Income towards Common Stockholders Growth (1y) (2018 - 2026)
Quanterix (QTRX) Net Income towards Common Stockholders Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -18.72% |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 13.91% |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 18.55% |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 98.96% |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 89.28% |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -30.10% |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 121.14% |
| 10 | Quanterix | 171.71 Mn | 72.44 Mn | 15.57 Mn | 14.45% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.45% |
| Dec 31, 2025 | -98.80% |
| Sep 30, 2025 | -301.26% |
| Jun 30, 2025 | -306.29% |
| Mar 31, 2025 | -83.68% |
| Dec 31, 2024 | -31.94% |
| Sep 30, 2024 | -24.37% |
| Jun 30, 2024 | -33.08% |
| Mar 31, 2024 | -53.46% |
| Dec 31, 2023 | 51.57% |
| Sep 30, 2023 | 81.63% |
| Jun 30, 2023 | 79.37% |
| Mar 31, 2023 | 59.41% |
| Dec 31, 2022 | -1.74% |
| Sep 30, 2022 | -133.38% |
| Jun 30, 2022 | -126.16% |
| Mar 31, 2022 | -77.36% |
| Dec 31, 2021 | -82.12% |
| Sep 30, 2021 | -810.89% |
| Jun 30, 2021 | 3.29% |